CONTACT: Amgen, Thousand Oaks Ashleigh Koss, 805-313-6151 (media) Arvind Sood, 805-447-1060 (investors)(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO) SOURCE Amgen
Regeneron has faced a lower stock price and patent wrangling. But the stock could be ready to rise again.
There could be a major windfall for Fortune 500 companies.
Apple could be the biggest winner if the Trump administration grants U.S. companies a repatriation tax holiday.